Literature DB >> 19796748

Trials comparing cytology with human papillomavirus screening.

M Arbyn, G Ronco, C J L M Meijer, P Naucler.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19796748     DOI： 10.1016/S1470-2045(09)70296-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  15 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Authors:  Carole Fakhry; Barbara T Rosenthal; Douglas P Clark; Maura L Gillison
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

3.  Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

Authors:  Fang-Hui Zhao; Margaret Jane Lin; Feng Chen; Shang-Ying Hu; Rong Zhang; Jerome L Belinson; John W Sellors; Silvia Franceschi; You-Lin Qiao; Philip E Castle
Journal:  Lancet Oncol       Date:  2010-11-11       Impact factor: 41.316

4.  Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.

Authors:  C E Depuydt; I H Benoy; J F A Beert; A M Criel; J J Bogers; M Arbyn
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

Review 5.  EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.

Authors:  Marc Arbyn; Silvia de Sanjosé; Mona Saraiya; Mario Sideri; Joel Palefsky; Charles Lacey; Maura Gillison; Laia Bruni; Guglielmo Ronco; Nicolas Wentzensen; Julia Brotherton; You-Lin Qiao; Lynnette Denny; Jacob Bornstein; Laurent Abramowitz; Anna Giuliano; Massimo Tommasino; Joseph Monsonego
Journal:  Int J Cancer       Date:  2012-07-02       Impact factor: 7.396

6.  Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Authors:  Mark Schiffman; Walter K Kinney; Li C Cheung; Julia C Gage; Barbara Fetterman; Nancy E Poitras; Thomas S Lorey; Nicolas Wentzensen; Brian Befano; John Schussler; Hormuzd A Katki; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

7.  Strategies for Increasing Cervical Cancer Screening Amongst First Nations Communities in Northwest Ontario, Canada.

Authors:  Marion Maar; Pamela Wakewich; Brianne Wood; Alberto Severini; Julian Little; Ann N Burchell; Gina Ogilvie; Ingeborg Zehbe
Journal:  Health Care Women Int       Date:  2014-11-24

8.  Optimizing technology for cervical cancer screening in high-resource settings.

Authors:  Lyndsay A Richardson; Joseph Tota; Eduardo L Franco
Journal:  Expert Rev Obstet Gynecol       Date:  2011-05

9.  Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.

Authors:  Karl Ulrich Petry; Alexander Luyten; Annika Justus; Angelika Iftner; Sarah Strehlke; Renate Schulze-Rath; Thomas Iftner
Journal:  BMC Infect Dis       Date:  2012-12-21       Impact factor: 3.090

10.  HPV testing by cobas HPV test in a population from Catalonia.

Authors:  Belén Lloveras; Silvia Gomez; Francesc Alameda; Beatriz Bellosillo; Sergi Mojal; Mercè Muset; Manuel Parra; José Carlos Palomares; Sergi Serrano
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.